Meridian Bioscience (VIVO) 10-K2020 FY Annual report

Filed: 23 Nov 20, 11:33am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Avg

New words: absenteeism, accompanyingConsolidated, adjustmentson, alsohad, andC, Anthony, antibody, antigenH, APM, Appendix, arecurring, ASC, atSeptember, attack, avoid, avoided, benefitsof, Bihl, breath, BreathID, burden, Campylobacter, certainty, champion, Changzhou, checking, choice, cleaning, combat, combo, competitor, confirmed, contact, core, covenant, demonstrating, deoxyribonucleotide, dictated, distancing, Dr, dramatically, earlier, earnout, easing, eleven, emerge, emerged, emergency, empowered, encourage, epidemic, equated, ethnically, evel, Exalenz, exploring, feedback, feel, forinterest, foundation, furlough, gap, GenBody, grew, hall, hindsight, home, house, hygiene, identification, ill, illustrated, imperative, incapacitated, inH, innovative, inspired, insufficient, intact, intent, Israe, Israel, Israeli, IVDR, Japan, Jersey, legitimate, liver, LocationWithin, lockdown, Manasquan, master, Merger, mission, monoclonal, month, NIS, noncancelable, nonessential, Nonqualified, notified, Occupational, ofHelicobacter, ofSeptember, ofthe, Oridion, OSHA, Otsuka, outlay, pace, pandemic, people, pretax, prioritization, proud, pursuit, quarantine, ratified, rebound, recombinant, reformlegislation, refreshed, renew, renewal, repaid, repair, representation, ribonucleic, ROU, sanitation, sanitizing, scale, sellable, shekel, Shiga, shortly, showcase, shut, skilled, slower, sort, spread, strive, striving, strongly, subside, telework, temperature, temporarily, tenure, theaccompanying, threat, top, Topic, town, track, trend, Trust, turned, turnover, unique, unprecedented, unusual, upholding, urea, vi, viability, vii, vitro, voice, wellbeing, withholding, withMr, workplace, Wuhan

Removed: accomplish, accurate, adaptable, andH, antibiotic, assistance, bacteria, Barbara, batching, Bioline, book, branded, breached, Cardinal, classify, compensatory, complaint, complemented, consummate, cough, court, decentralized, detecting, discontinue, District, economical, enhancing, EnterohemorrhagicE, excise, expectedly, false, fast, faster, Fisher, Forman, fragmented, hour, importantly, incorrectly, leasing, lowering, loyalty, malaria, misleading, MyTaq, network, notice, OurC, phasing, pinpoint, pipeline, plaintiff, played, pneumoniae, properly, published, purity, reach, reliable, remediate, repeal, repeat, requiring, role, rubella, run, sensifast, sensor, serve, Similarly, Simplex, size, sourcing, Southern, span, specifically, specimen, supplemented, turnaround, USA, vendor, WFOE, whooping

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated VIVO transcripts

VIVO similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32

Certification of Chief Executive Officer and Chief Financial Officer

Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the filing with the Securities and Exchange Commission of the Annual Report of Meridian Bioscience, Inc. (the “Company”) on Form 10-K for the period ended September 30, 2020 (the “Report”), the undersigned officers of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of their knowledge:

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Jack Kenny

Jack Kenny

Chief Executive Officer

November 23, 2020

/s/ Bryan T. Baldasare

Bryan T. Baldasare

Executive Vice President and

Chief Financial Officer

November 23, 2020